NRG

NRG, founded in 1998, operates within the Energy, Utilities & Waste Treatment and Electricity, Oil & Gas sectors. Based in Petten, Netherlands, the company specializes in developing and manufacturing nuclear medicines. Its core mission involves researching and advising on safe nuclear energy for existing power plants and exploring innovative concepts like thorium reactors. With a single primary location, NRG addresses complex challenges in the nuclear energy landscape.

The company's operational scope includes services for nuclear technology, radioactive isotopes, and medical isotopes, vital for medical applications and energy production. NRG also handles the safe transport and disposal of radioactive waste, using advanced techniques and computer models for safety assessments. Their team ensures the safe operation of nuclear facilities and develops new technological solutions. Meet NRG's team to understand the expertise driving these critical operations. The company employs 500 - 1,000 professionals.

NRG's portfolio covers nuclear-related activities, from raw material handling to reactor operation and the development of radiation safety monitoring equipment. They offer consultancy services, licensing support, and training courses in radiation safety and decontamination. Their commitment extends to pioneering new reactor concepts like molten salt reactors, contributing to the future of European Union energy policy and safe nuclear technology deployment.